Eric Halioua, President & CEO of PDC*line Pharma will be a panelist in the Advances in Cell & Gene Therapies round table at the 11th Annual European Life Sciences CEO Forum. A Sachs Associates event...
PDC*line Pharma CEO and COO will be in San Francisco (USA) during the JP Morgan conference, January 8–10, 2017.
PDC*line Pharma’s CMO and CSO will be present at ESMO Immuno Oncology Congress in Geneva, Switzerland – 07 Dec – 10 Dec 2017. A poster will be presented describing our last results with Neo-Antigens...
Eric Halioua, President & CEO of PDC*line Pharma will be chairman at a roundtable session on “How to keep the founding scientists committed?” at BioFIT partnering event, Strasbourg (France) , November...
Eric Halioua, President & CEO of PDC*line Pharma will be chairman at a roundtable session on “Next generation therapeutic vaccines : viral, bacterial and cell based” at World Immunotherapy Congress in...
Eric Halioua, President & CEO of PDC*line Pharma will present the company at the Sachs Associate 17th Annual Biotech in Europe Forum in Basel Wednesday September 27th.
Eric Halioua, CEO of PDC*line Pharma will be speaker at an official satellite workshop at BIO US (San Diego, CA – US) to present the company strategy for new immunotherapies. The workshop entitled “Wi...
We are very pleased to inform you that the 8th edition of MATWIN’s international board has awarded PDC*line Pharma with the prize of most promising project in the “start-up” category.
This prize...
Three Belgian investment funds and several specialized international business angels have participated in this round, which will allow the company’s cancer immunotherapy technology to reach the...
PDC*line Pharma will attend BIO-Europe in Cologne (Germany)
November 7–9, 2016
Cologne, Germany
Let’s meet there !
